Express News | WHO Launches Global Strategic Preparedness And Response Plan To Contain Mpox Outbreak
Express News | WHO: Côte D'Ivoire Reports First Cases Of Clade II Mpox Since The Start Of The Multi-Country Outbreak In 2022
'Mpox In Wayne County: Health Department Confirms First Case Since 2022' - Fox 2 Detroit
Express News | Africa CDC Director General Says Mpox Vaccination To Begin In Democratic Republic Of Congo And Other Countries Within Days If Preparations Are Complete
Mpox Outbreak Has World on High Alert. What to Know
The only manufacturer of smallpox vaccine has submitted clinical data and plans to expand the scope of vaccination.
Bavarian Nordic announced that it has submitted clinical data to the European Medicines Agency to seek an expansion of the indication for its Imvanex vaccine to adolescents aged 12-17. Yesterday, Sweden, the neighboring country of Denmark, reported the first confirmed case of monkeypox, which is also the first case confirmed outside the African continent since this epidemic outbreak.
Express News | Vaccine Group Gavi Says It Has Up To $500M Available For Mpox Response
Express News | WHO Says Expert Committee Will Propose Adoption Of Mpox Vaccines Under Emergency Use Listing Around Mid Sept
Express News | WHO Director-General Tedros Adhanom Ghebreyesus Says Mpox Is Public Health Emergency Of International Concern
Express News | WHO Press Conference On Potential Mpox Emergency Declaration Begins
Express News | Africa CDC Declares Mpox A Public Health Emergency Of Continental Security
Express News | Inovio Pharmaceuticals Inc Files for Common Stock Offering of up to $60 Mln - SEC Filing
Analysts Offer Insights on Healthcare Companies: Universal Health (UHS) and Inovio Pharmaceuticals (INO)
Express News | Inovio Pharmaceuticals, Inc. : Oppenheimer Cuts Target Price to $33 From $40
Inovio Pharmaceuticals (INO) Receives a Buy From Oppenheimer
We Think Inovio Pharmaceuticals (NASDAQ:INO) Needs To Drive Business Growth Carefully
Express News | RBC Capital Maintains Sector Perform on Inovio Pharmaceuticals, Lowers Price Target to $8
Inovio Pharmaceuticals Analyst Ratings
Inovio Pharmaceuticals: Hold Rating Amidst Financial Concerns and INO-3107 Development Delays
Express News | Inovio Pharmaceuticals Inc : H.c. Wainwright Cuts Target Price to $12 From $15